Abstract

目的评价HEAD-US评估量表在血友病性关节病临床应用的可行性,提出优化的超声评估量表HEAD-US-C。方法2015年7月至2017年8月期间,91例血友病患者接受1 035例次关节超声检查,分别采用Melchiorre、HEAD-US、HEAD-US-C量表进行评分,分析与血友病关节健康评分量表(HJHS)评分之间的相关性并比较上述量表评价血友病性关节病的敏感性。结果91例患者均为男性,中位年龄16(4~55)岁,血友病A 86例,血友病B 5例。1 035例次关节检查Melchiorre、HEAD-US、HEAD-US-C量表的评分[M(P25, P75)]分别为2(0,6)、1(0,5)、2(0,6),均与HJHS评分之间存在相关关系(相关系数分别为0.747、0.762、0.765,P值均<0.001)。Melchiorre、HEAD-US-C、HEAD-US评分量表的阳性率分别为63.0%(95%CI 59.7%~65.9%)、59.5%(95%CI 56.5%~62.4%)、56.6%(95%CI 53.6%~59.6%),差异有统计学意义(P<0.001)。336例次无症状关节(HJHS评分0分)Melchiorre、HEAD-US-C、HEAD-US评分量表的阳性率分别为25.0%(95%CI 20.6%~29.6%)、17.0%(95%CI12.6%~21.1%)、11.9%(95%CI 8.4%~15.7%)(P<0.001)。40例有关节出血症状的血友病患者(107例次)关节出血前、出血后超声评分差异有统计学意义(P<0.05)。HEAD-US-C与HEAD-US评分的变化幅度比较,差异有统计学意义(P<0.001)。结论与Melchiorre比较,HEAD-US、HEAD-US-C与HJHS之间具有相似的良好的相关性。HEAD-US-C评分量表较HEAD-US更为敏感,尤其适合亚临床状态血友病性关节病的评估。

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.